In vitro neurogenic and musculotropic responses to angiotensin peptides in normal and sodium-restricted rabbits.
D000804:Angiotensin II / Q000031:analogs & derivatives* / Q000494:pharmacology*; D000805:Angiotensin III / Q000494:pharmacology*; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects; D004558:Electric Stimulation; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D018377:Neurotransmitter Agents; D009638:Norepinephrine / Q000494:pharmacology; D011169:Portal Vein / Q000187:drug effects / Q000294:innervation; D011817:Rabbits; D011941:Receptors, Adrenergic / Q000187:drug effects; D012504:Saralasin / Q000494:pharmacology*; D012964:Sodium / Q000172:deficiency; D014649:Vas Deferens / Q000187:drug effects / Q000294:innervation
D018377:Neurotransmitter Agents; D011941:Receptors, Adrenergic; D000804:Angiotensin II; D000805:Angiotensin III; D012964:Sodium; D012504:Saralasin; D009638:Norepinephrine